Ariviya is a deep tech startup specializing in nanobiopolymer technology to develop disinfectants, therapeutics, and biosensors for human and animal health, focusing on chemical-free, high-efficacy solutions for hygiene and wound care.
Ariviya is a deep tech startup that leverages nanotechnology, biotechnology, and polymer technology to develop innovative solutions for pathogen detection, disease prevention, and hygiene management. The company invents drugs, disinfectants, and biosensors designed to solve real-world problems across industries including agriculture, animal health, and human wound care. Their approach centers on stabilizing nanoparticles on biopolymers through proprietary bioprocesses, creating scalable, natural, and high-efficacy products that aim to reduce chemical dependency and toxic residues in medical and industrial applications.
These advancements are crucial for customers seeking cleaner, safer alternatives for sanitization and therapeutic care. Ariviya provides a range of products, such as surface disinfectants for farms and households, udder care solutions for dairy livestock, and specialized sprays for wound and burn management. By offering technologies that support hygiene and healing while maintaining environmental safety, the company addresses significant operational challenges in both the veterinary and healthcare sectors. Their work is supported by incubation at multiple technology business foundations and reflects a commitment to science-led innovation in practical, everyday-use applications.